The vaccine was made by the company Moderna, one of five US firms that the Trump administration tasked with developing a cure for the disease. On 27 July, Moderna will start its most important trials to see whether their product protects against the infection from SARS-CoV-2.

Axar.az reports Israel secured a multimillion deal on a coronavirus vaccine reportedly worth $66 million, but Channel 12 reports that the nation risks ending up with no cure for the infectious disease that has killed more than 600,000 people across the world, as the country is lacking syringes used to inject vaccines.

Israeli media reports say other countries took care of this issue. The United States, which has been hit the hardest by the disease, bought 50 million syringes, while the European Union, another epicentre of the coronavirus outbreak, said it would need about a billion needles and syringes to vaccinate the continent.